CellCarta and Imagene AI Expand Collaboration to Validate, Deploy and Scale AI-Powered Biomarker and Companion Diagnostic Programs Across Drug Development
This collaboration highlights advancements in AI applications for healthcare diagnostics, potentially improving drug development efficiency.
This collaboration highlights advancements in AI applications for healthcare diagnostics, potentially improving drug development efficiency.
Auto-scored: Event is a benign business development in AI medicine with no direct risk or mitigation elements.